- Home
- PRTS vs RNXT Comparison
PRTS vs RNXT Comparison
Compare PRTS & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- RNXT
- Stock Information
- Founded
- PRTS 1995
- RNXT 2012
- Country
- PRTS United States
- RNXT United States
- Employees
- PRTS N/A
- RNXT N/A
- Industry
- PRTS Auto & Home Supply Stores
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- RNXT Health Care
- Exchange
- PRTS Nasdaq
- RNXT Nasdaq
- Market Cap
- PRTS 40.0M
- RNXT 44.6M
- IPO Year
- PRTS 2007
- RNXT 2021
- Fundamental
- Price
- PRTS $0.76
- RNXT $1.27
- Analyst Decision
- PRTS Hold
- RNXT Strong Buy
- Analyst Count
- PRTS 1
- RNXT 2
- Target Price
- PRTS $0.70
- RNXT $7.50
- AVG Volume (30 Days)
- PRTS 1.4M
- RNXT 579.5K
- Earning Date
- PRTS 10-28-2025
- RNXT 11-12-2025
- Dividend Yield
- PRTS N/A
- RNXT N/A
- EPS Growth
- PRTS N/A
- RNXT N/A
- EPS
- PRTS N/A
- RNXT N/A
- Revenue
- PRTS $577,614,000.00
- RNXT $662,000.00
- Revenue This Year
- PRTS N/A
- RNXT $2,988.37
- Revenue Next Year
- PRTS $2.62
- RNXT $300.60
- P/E Ratio
- PRTS N/A
- RNXT N/A
- Revenue Growth
- PRTS N/A
- RNXT N/A
- 52 Week Low
- PRTS $0.68
- RNXT $0.75
- 52 Week High
- PRTS $1.42
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- PRTS 41.21
- RNXT 60.58
- Support Level
- PRTS $0.84
- RNXT $1.06
- Resistance Level
- PRTS $1.36
- RNXT $1.45
- Average True Range (ATR)
- PRTS 0.12
- RNXT 0.11
- MACD
- PRTS -0.02
- RNXT 0.03
- Stochastic Oscillator
- PRTS 1.48
- RNXT 67.27
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.